Assessment and clinical relevance of non-fasting and postprandial triglycerides: an expert panel statement

GD Kolovou, DP Mikhailidis, J Kovar… - Current vascular …, 2011 - ingentaconnect.com
GD Kolovou, DP Mikhailidis, J Kovar, D Lairon, BG Nordestgaard, T Chye Ooi…
Current vascular pharmacology, 2011ingentaconnect.com
An Expert Panel group of scientists and clinicians met to consider several aspects related to
non-fasting and postprandial triglycerides (TGs) and their role as risk factors for
cardiovascular disease (CVD). In this context, we review recent epidemiological studies
relevant to elevated non-fasting TGs as a risk factor for CVD and provide a suggested
classification of non-fasting TG concentration. Secondly, we sought to describe
methodologies to evaluate postprandial TG using a fat tolerance test (FTT) in the clinic …
An Expert Panel group of scientists and clinicians met to consider several aspects related to non-fasting and postprandial triglycerides (TGs) and their role as risk factors for cardiovascular disease (CVD). In this context, we review recent epidemiological studies relevant to elevated non-fasting TGs as a risk factor for CVD and provide a suggested classification of non-fasting TG concentration. Secondly, we sought to describe methodologies to evaluate postprandial TG using a fat tolerance test (FTT) in the clinic. Thirdly, we discuss the role of non-fasting lipids in the treatment of postprandial hyperlipemia. Finally, we provide a series of clinical recommendations relating to non-fasting TGs based on the consensus of the Expert Panel: 1). Elevated non-fasting TGs are a risk factor for CVD. 2). The desirable non-fasting TG concentration is
ingentaconnect.com